Multidisciplinary Parkinson rehabilitation in the Netherlands: The effectiveness of points of Parkinson (POP)
Objective: To analyze the effect of the POP rehab program for advanced PD patients on motor- and non-motor symptoms up to 2 years and determine…Effect of botulinum toxin on the non-motor symptoms of dystonia
Objective: To assess the prevalence of non-motor symptoms (NMS) in patients with cervical dystonia and dystonic head tremor receiving standard botulinum toxin (BoNT) treatment and…Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?
Objective: To characterize the abnormalities in pulmonary function tests (PFT) in early-diagnosed PD patients and to assess their prognostic features 2 years after. Background: Pulmonary…Neuropsychological assessment in the Luxembourg Parkinson’s cohort (HELP-PD)
Objective: To report first results on the prevalence of cognitive non-motor symptoms in the Luxembourg Parkinson's cohort (HELP-PD). Background: HELP-PD aims to combine thorough assessment…Exploring structural covariance networks of gray matter in Parkinson’s disease
Objective: To investigate whether structural covariance networks (SCNs) can be used to detect disease-specific patterns of gray matter atrophy in Parkinson's disease (PD) and secondly,…Outpatient management of Parkinson’s disease: A review of medication changes made to address both motor and non-motor symptoms
Objective: To identify reasons for medication changes at outpatient movement disorder clinics and determine outcome of these changes at next clinic visit. Background: Parkinson's disease…Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life
Objective: To highlight the frequency of non motor symptoms in patients with Parkinson's disease and to evaluate their impact on quality of life. Background: Parkinson's…Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment
Objective: To assess the usefulness and metric properties of a transcribed version of the Frenchay Dysarthria Assessment 2 (FDA-2) for speech evaluation in a cohort…Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease
Objective: To explore the relation between the non-motor symptoms (NMS) of PD and the involvement of brainstem through studying VEMPs. Background: Degeneration of several brainstem…Pallidal versus subthalamic stimulation for PD: Beyond the motor effects
Objective: To evaluate the effects of Deep Brain Stimulation(DBS) on non motor symptoms(NMS) in Parkinson's disease(PD) and compare the efficacy of pallidal(GPi) versus subthalamic(STN) stimulation.…
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 51
- Next Page »